Company Intelligence Profile
Hospilab Technology Private Limited
Hospilab Technology Pvt Ltd operates a chain of clinical diagnostic laboratories (pathology/biochemistry/hematology/microbiology/molecular testing) serving doctors, clinics, nursing homes and hospitals.
Last updated 17 August 2026
Hospilab Technology Private Limited operates a chain of clinical diagnostic laboratories across Karnataka, offering services in pathology, biochemistry, hematology, microbiology, and molecular testing. In FY2025, the company achieved a revenue of ₹5.07 crore, marking a 115% year-over-year growth, with a net profit margin of 7.03% and a return on equity of 7.53%.
Compiled from MCA filings and other public records. Figures may lag the latest filing; verify against the detailed sections below.
See what AICA knows about Hospilab Technology
Deeper analysis, financial signals and peer comparisons.
Company Identity
| Registered name | Hospilab Technology Private Limited |
|---|---|
| CIN | U85100KA2022PTC167383 |
| PAN | Not available in the public sources reviewed. |
| Status | Active |
| Listing | Unlisted / not listed (private limited company) |
| Incorporated | 27 October 2022 |
| ROC | RoC-Bangalore |
| Sector (NIC) |
|
| Registered address | Address conflict between sources (both RT Nagar, Bangalore 560032, Karnataka): - Tofler: "No 9, 1st cross Road, P & T colony, gangenahali RT Nagar, Bengaluru, Bangalore, Karnataka - 560032" - TheCompanyCheck: "Ground Floor No.97 8th Main Road, 8th Cross Hmt Layout Ganganagar, Bangalore North, Karnataka, India – 560032" |
| Authorized capital | ₹10,00,000 (₹10 lakh) |
| Paid-up capital | ₹10,00,000 (₹10 lakh) |
Business Overview
- Hospilab Technology Pvt Ltd operates a chain of clinical diagnostic laboratories (pathology/biochemistry/hematology/microbiology/molecular testing) serving doctors, clinics, nursing homes and hospitals
- Per WebSearch/company listings it has branches in Bangalore, Udupi, Hassan, Bagalkot and Bijapur (Karnataka)
- Recognised as a DPIIT startup
- Website: hospilab.in (React SPA, could not scrape content directly — could not verify further detail beyond aggregator summaries)
Directors
Five directors identified (Tofler, DINs from Tofler; names corroborated by TheCompanyCheck for 3 of them):
| Name | DIN | Role | Appointed |
|---|---|---|---|
| Lakshminarayanan Koyalmannam Krishnamurthy | 07555558 | - | - |
| Preety Nandy | 08487170 | - | - |
| Vignesh Prasad | 08560279 | - | - |
| Mohammed Shafiulla Shali | 08889362 | - | - |
Financials
FY2025 (year ended 31 Mar 2025), standalone (private company, no subsidiaries indicated):
| Revenue | ₹5.07 Cr, up 115% YoY |
|---|---|
| EBITDA | not obtained |
| PAT | not obtained (locked) |
| Net Profit Margin | 7.03%, Return on Equity: 7.53%, Debt-to-Equity: 0.18, Gross Margin: 0.27 |
| Net worth / borrowings | not obtained |
No audited filing/annual report PDF was located; all figures are aggregator-derived and single-sourced — treat as partial confidence only.
Charges & Borrowings
- TheCompanyCheck lists one open charge of ₹1.2 Cr with Canara Bank, registered 29 Oct 2025
- Tofler (updated 18 Jul 2026) states "No registered charges on assets." Given TheCompanyCheck's more recent charge-registration date, the Canara Bank charge is plausible but not corroborated by a second source — treat as partial/unconfirmed
Legal (Indian Kanoon)
No court cases or legal proceedings found on Indian Kanoon for "Hospilab Technology" — search returned no matching results.
Competitors
Frequently Asked Questions
What does Hospilab Technology Private Limited do?
What is the CIN of Hospilab Technology Private Limited?
Where is Hospilab Technology Private Limited registered?
When was Hospilab Technology Private Limited incorporated?
Explore on Recur Club
Bharat Ke Super Founders
Recur Club's show spotlighting the founders building India's next generation of companies. Watch their stories.
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.